- Patients
- Professionals
- Partners in Care
- Get a Sample
Menu
Medifil® II Collagen Particles is a Kollagen™ product that gives a wound both biological and physical qualities. The particles have a large surface area, allowing them to effectively penetrate the wound surface and release the maximum quantity of collagen. Medifil® II is a non-hydrolyzed type 1 bovine native collagen that is 100% non-hydrolyzed. This technology approach developed by Human BioSciences, Inc. protects and retains considerably more native triple helical protein structure, providing for enhanced molecule and scaffold stability during all four phases of wound healing.
Advanced wound care solutions are focused on the wound’s microenvironment and are meant to maintain an ideal moist wound environment. Proper wound healing necessitates a moist wound healing environment. HBS uses a patented manufacturing technology called “Kollagen™” to create its native or aka non-hydrolyzed bovine type I collagen product.
Medifil® II Collagen Particles are bioactive material products that interact with the wound microenvironment on a cellular and molecular level, assisting the body’s natural healing process. HBS’ native or aka non-hydrolyzed collagen is the “purest form” of collagen. Non-hydrolyzed collagen preserves a higher percentage of its native triple helix protein structure during wound healing, resulting in increased molecular and scaffold stability. Collagen must maintain its triple helix structure to improve heat endurance, mechanical strength, and the ability to engage in precise interactions with other biomolecules.
Application of Medifil® II Collagen Particles
Features & Benefits of Medifil® II Collagen Particles
Absorbs 40-60 times its weight in fluid
Accelerates healing
Balances the wound microenvironment
Higher protein structure of collagen
Mimic’s the body’s own collagen
Easy pour vial in compliance with infection control
Indications include:
Warnings:
Learn more www.humanbiosciences.com
Request samples https://humanbiosciences.com/prescription-products/
Human BioSciences, Inc. blog offers education and tips; however,the information provided by this website or company is not a substitute for medical treatment or advice.
Mrs. Vann is responsible for branding, design, and public outreach efforts for the company. Mrs. Vann has over five years of experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international. She also has experience producing several television and live-stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.
Mr. Patel is the Vice President of Operations for Human BioSciences. As such, he is responsible for strategy development for optimal growth, organizing multiple teams and implementing optimal product delivery for the growth of HBS. He has served multiple positions within HBS since 2001, including Operations Manager. With an MBA in Pharmaceutical Healthcare and a Bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge in collagen product production with a rich history in managing teams.
As the President of Human BioSciences, Dr. Rohan K Jain is responsible for the company’s overall operations, with a focus on research and development. Dr. Jain has supervised and conducted extensive research in the collagen, biomaterials, and protein space, resulting in the release of numerous new products to the market. Prior to his role at HBS, Dr. Jain was a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University; his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.
Cheryl Carver, LPN, WCC, CWCA, CWCP, DAPWCA, FACCWS is responsible for clinical education and training initiatives for customer accounts. Ms. Carver has amassed a wealth of clinical knowledge and industry experience in her more than 20 years as a board-certified wound care nurse. She has authored over 200 published white papers, ebooks, blogs, and articles for WoundSource and freelance.
Dr. Goebel is responsible for the company’s physical infrastructure and global expansion efforts through partnerships. Prior to joining HBS, Dr. Goebel was Managing Director at the Graf Matuschka Group in Munich, Germany, where he was actively involved in restructuring and privatization in East Germany and Eastern Europe. He was also a member of the American group of the EBRD European Bank for Reconstruction and Development in the privatization of the Russian economy and military complex. He has over forty years’ experience in many different industries including medical devices, pharmacy, and others. Dr. Goebel earned his Doctorate and Postdoctoral degrees in Economics in East Berlin.
Mr. Kumar is responsible for the company’s overall accounting and finance activities with a focus on internal control and taxation.
Mr. Kumar has over 25 years of public and corporate accounting experience. He is a Certified Public Accountant, licensed in the State of Virginia, Maryland, and Washington D.C., and an Enrolled Agent authorized to practice before the Internal Revenue Service. Mr. Kumar is also a Chartered Accountant and fellow member of the Institute of Chartered Accountants of India. Mr. Kumar received his Master’s degree in Commerce from Himalayan University in India.
Mr. Slovick is responsible for all regulatory and quality affairs in the company. Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years. He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.
Mr. Agarwal is responsible for Corporate Business Development, Sales, and Product Development, both locally and internationally for the company. Mr. Agarwal has over six years of corporate sales and business development experience. He completed his Master of Science in Engineering Management degree from Johns Hopkins University with a technical concentration in Mechanical Engineering. In the past, he has also worked as a fundraising volunteer for three years and thus gained insights in community fundraising and business development. Additionally, he has interned at a manufacturing firm and understood various intricacies involved in manufacturing ranging from the floor level to the supply chain. He has published a paper on Omni Channel Supply Chain and is a certified Lean Six Sigma associate. He has also interned as a business development consultant to a startup for market research and pricing strategies in Israel. Equipped with a combination of management and technical background acquired from his diverse experiences and education, he is perfectly suited to lead the business development efforts for Human BioSciences.